Is stab with stranglation the fastest way to kill esophageal varices?
スポンサーリンク
概要
- 論文の詳細を見る
- 1999-04-01
著者
-
Iwao Tadashi
Division Of Gastroenterology Department Of Medicine Kurume University School Of Medicine
-
TOYONAGA ATSUSHI
Division of Gastroenterology and Endoscopy, Kurume University School of Medicine
-
Toyonaga Atsushi
Division Of Gastroenterology And Endoscopy And Department Of Medicine Ii Kurume University School Of
-
Toyonaga Atsushi
Division Of Gastroenterology And Endoscopy Kurume University School Of Medicine
-
Iwao Tadashi
Division Of Gastroenterology And Endoscopy Kurume University School Of Medicine
関連論文
- Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
- Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
- Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
- New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
- Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
- Systemic Sclerosis Associated with Diabetes Insipidus
- Intestinal microflora as a therapeutic target in inflammatory bowel disease
- Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
- Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon
- Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
- Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
- Two-year follow-up study after treatment with lamivudine for chronic hepatitis B : seven cases reported
- Erythropoietic protoporphyria with fatal liver failure
- Lack of detection of hepatitis C virus replicative intermediate in abdominal lymph nodes
- Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
- Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
- A pilot study of natural interferon γ therapy for chronic hepatitis C
- Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA
- A Case with Multiple Colonic Ulcers Simulating Churg-Strauss Syndrome
- Mechanisms of thrombocytopenia induced by interferon therapy for chronic hepatitis B
- Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
- Second generation amplicor-HCV monitor assay : clinical features and predictors of the response to interferon
- Should B-RTO Be the First-Line Treatment for Portosystemic Encephalopathy?
- Clinical implications of the red color sign on esophageal varices
- Is stab with stranglation the fastest way to kill esophageal varices?
- Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C